Cannabinoid Products Company Provides Updates on Global Clinical Research Program, Which Includes Sleep Research

Cannabinoid products company Spectrum Therapeutics, the medical division of Canopy Growth Corp, shares an update on its efforts to develop and commercialize validated cannabis medicines through clinical trials.Spectrum Therapeutics is pursuing research to introduce products for the therapeutic areas of pain, mood, and sleep and to gain access to new markets independent of medical cannabis laws.

Clinical Research

Spectrum Therapeutics is focused over the next 24 months to further the science of cannabinoids and provide evidence by way of clinical trials on what conditions medical cannabis can treat. This research includes product design and ingredient selection, formulation, and safety and efficacy testing towards the development of standardized cannabis drug formulations and dose delivery systems. Research activity is occurring in two main areas: registration trials and exploratory studies.

Registration trials begin with phase I studies of cannabinoid products covering a spectrum of proprietary THC and CBD ratios. These initial trials provide

... read more at: http://www.sleepreviewmag.com/2019/06/cannabinoid-products-company-provides-updates-global-clinical-research-program-includes-sleep-research/